Sarepta Therapeutics
Cambridge, US
Biotech
Founders & leadership
WW
WILLIAM W. CIAMBRONEExecutive Officer
HW
HANS W. WIGZELLDirector
CW
CLAUDE W. NICAISEDirector
DS
DOUGLAS S. INGRAMExecutive Officer, Director
DT
DAVID TYRONNE HOWTONExecutive Officer
MA
MARY ANN W. GRAYDirector
ST
SANDESH TYRONNE MAHATMEExecutive Officer
GT
GILMORE TYRONNE O'NEILLExecutive Officer
MK
M. KATHLEEN BEHRENSDirector
RJ
RICHARD J. BARRYDirector
MW
MICHAEL W. BONNEYDirector
AS
ALEXANDER S. CUMBOExecutive Officer
Reported raises · per SEC filings
Form D private placements$400MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)$30.5MraisedNov 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.